CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (170,700)	$ (50,826)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity in (earnings) losses of unconsolidated ventures	36,799	7,666
Depreciation and amortization	48,929	54,525
Impairment loss	91,437	10,146
Capitalized interest for mortgage and other notes payable	222	193
Amortization of below market debt	2,311	2,253
Straight-line rental income, net and amortization of lease inducements	224	(478)
Amortization of discount/accretion of premium on investments	(92)	(83)
Amortization of deferred financing costs	1,416	1,367
Amortization of equity-based compensation	123	136
Realized (gain) loss on investments and other	0	(5,926)
Allowance for uncollectible accounts	1,803	595
Issuance of common stock as payment for asset management fees	7,500	7,500
Changes in assets and liabilities:
Receivables	(4,363)	(790)
Other assets	4,961	(644)
Due to related party	(1,896)	(1,330)
Escrow deposits payable	1,137	1,739
Accounts payable and accrued expenses	8,274	(5,257)
Other liabilities	(105)	(743)
Net cash provided by operating activities	27,980	20,043
Cash flows from investing activities:
Capital expenditures for operating real estate	(8,990)	(14,644)
Sale of operating real estate	927	19,618
Investment in unconsolidated ventures	0	(39,801)
Distributions from unconsolidated ventures	1,963	16,846
Other assets	(35)	934
Net cash (used in) investing activities	(6,135)	(17,047)
Cash flows from financing activities:
Borrowings from mortgage notes	0	12,800
Repayment of mortgage notes	(14,418)	(45,868)
Borrowings from line of credit - related party	35,000	0
Payment of deferred financing costs	0	(708)
Payments under finance leases	(457)	(424)
Shares redeemed for cash	(1,998)	(7,416)
Distributions paid on common stock	0	(10,813)
Proceeds from distribution reinvestment plan	0	4,876
Contributions from non-controlling interests	168	430
Distributions to non-controlling interests	(151)	(213)
Net cash provided by (used in) financing activities	18,144	(47,336)
Net increase (decrease) in cash, cash equivalents and restricted cash	39,989	(44,340)
Cash, cash equivalents and restricted cash-beginning of period	58,820	94,508
Cash, cash equivalents and restricted cash-end of period	98,809	50,168
Supplemental disclosure of non-cash investing and financing activities:
Accrued capital expenditures	616	835
Assets acquired under finance leases	$ 112	$ 0